Valuation : Takeda Pharmaceutical Company Limited

Market Cap 9,26100Cr 5.79TCr 4.99TCr 4.68TCr 4.27TCr 8.04TCr 5,53300Cr 8.07TCr 55TCr 22TCr 2,79300Cr 22TCr 21TCr P/E 2027 *
46.6x
P/E 2028 * 29.8x
Enterprise Value 13,16300Cr 8.23TCr 7.09TCr 6.65TCr 6.07TCr 11TCr 7,86400Cr 11TCr 79TCr 31TCr 3,97000Cr 31TCr 30TCr EV / Sales 2027 *
2.81x
EV / Sales 2028 * 2.72x
Free-Float
99.26%
Yield 2027 *
3.52%
Yield 2028 * 3.59%
1 day-0.15%
1 week-0.43%
Current month+5.21%
1 month+0.54%
3 months+13.10%
6 months-0.33%
Current year+19.96%
1 week 5,759
Extreme 5759
5,906
1 month 5,225
Extreme 5225
5,906
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer 56 01/01/2025
Director of Finance/CFO 48 01/04/2024
Chief Tech/Sci/R&D Officer 47 01/02/2022
Director TitleAgeSince
Director/Board Member 60 01/06/2015
Director/Board Member 73 01/01/2019
Director/Board Member 48 01/06/2024
Date Insider Type Main position Quantity % Market Cap.
19/08/26 Sell

Chief Technology Officer

-19,651 0.0012%
18/08/26 Sell

Head of Human Resources

-12,980 0.0008%
11/08/26 Sell

Pres., Global Supply & Quality

-20,363 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-0.15%-0.43%+32.09%+30.37% 5.82TCr
-0.65%-7.04%+59.44%+110.69% 1,04800Cr
-0.05%-1.87%+51.14%+61.41% 64TCr
-0.67%-3.34%+23.12%+73.64% 46TCr
-1.46%-4.50%+37.43%+38.41% 36TCr
-0.72%-2.89%+21.86%+36.79% 29TCr
-1.19%-2.21%+1.35%+10.79% 26TCr
-1.04%-1.53%+51.47%+68.62% 24TCr
+0.08%-1.78%-17.64%-54.29% 20TCr
-2.40%-0.57%+29.07%+88.58% 18TCr
Average -0.79%-0.68%+28.93%+46.50% 37.4TCr
Weighted average by Cap. -0.70%-1.89%+37.91%+64.11%

Financials

2027 *2028 *
Net sales 4,68700Cr 2.93TCr 2.52TCr 2.37TCr 2.16TCr 4.07TCr 2,80000Cr 4.08TCr 28TCr 11TCr 1,41300Cr 11TCr 11TCr 4,76600Cr 2.98TCr 2.57TCr 2.41TCr 2.2TCr 4.14TCr 2,84700Cr 4.15TCr 29TCr 11TCr 1,43700Cr 11TCr 11TCr
Net income 19TCr 121.14Cr 104.38Cr 98Cr 89Cr 168.31Cr 12TCr 168.84Cr 1.16TCr 453.04Cr 5.84TCr 454.81Cr 444.92Cr 32TCr 198.49Cr 171.04Cr 160.36Cr 146.39Cr 275.77Cr 19TCr 276.65Cr 1.9TCr 742.32Cr 9.58TCr 745.22Cr 729Cr
Net Debt 3,90200Cr 2.44TCr 2.1TCr 1.97TCr 1.8TCr 3.39TCr 2,33100Cr 3.4TCr 23TCr 9.12TCr 1,17700Cr 9.16TCr 8.96TCr 3,70100Cr 2.31TCr 1.99TCr 1.87TCr 1.71TCr 3.21TCr 2,21100Cr 3.22TCr 22TCr 8.65TCr 1,11600Cr 8.69TCr 8.5TCr
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
28/26/28 JP¥5,800.00 -0.15% 30,17,700
27/26/27 JP¥5,809.00 -0.87% 25,56,600
26/26/26 JP¥5,860.00 +0.81% 30,73,000
25/26/25 JP¥5,813.00 +0.28% 30,25,100
24/26/24 JP¥5,797.00 +0.57% 25,68,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
5,800.00JPY
Average target price
6,515.81JPY
Spread / Average Target
+12.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock